Premium
Lichenoid drug reaction due to anti‐tubercular therapy presenting as erythroderma
Author(s) -
Katare Anusha,
Arora Pooja,
Sardana Kabir,
Malhotra Purnima
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13169
Subject(s) - medicine , erythroderma , dermatology , exfoliative dermatitis , drug reaction , tuberculosis , drug eruption , drug , adverse effect , first line , pathology , pharmacology
First‐line anti‐tubercular therapy (ATT) is very effective in management of tuberculosis and is usually well tolerated. Varied spectrum of cutaneous adverse drug reactions is associated with ATT, of which lichenoid drug eruption (LDR) constitutes approximately 10% of the cases. However, LDR presenting as erythroderma is very rare. Here, we report a case of exfoliative dermatitis secondary to LDR which developed after 5 months of ATT.